Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kuronuma (Sapporo, Japan), M. Otsuka (Sapporo, Japan), M. Wakabayashi (Toyonaka, Japan), T. Yoshioka (Toyonaka, Japan), Y. Morioka (Toyonaka, Japan), T. Kobayashi (Sapporo, Japan), M. Kameda (Sapporo, Japan), H. Chiba (Sapporo, Japan), H. Takahashi (Sapporo, Japan). Role of transient receptor potential vanilloid 4 in the therapeutic antifibrotic effects of pirfenidone. 1289

Member's Comments

No comment yet.

Related content which might interest you: The effect of leukotrienes and their receptor antagonists on calcium signalling in the cough receptors transient receptor potential ankyrin 1 (TRPA1) and vanilloid 1 (TRPV1) Source: Annual Congress 2010 - Models of airways disease Year: 2010 Anti-inflammatory and immunomodulatory potential of Cys LT1 receptor antagonists (LTRA) in steroid dependent persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005 Transient receptor potential vanilloid 4 channels mediate resistive breathing-induced acute lung injury. Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Calcium-sensing receptor as a therapeutic target for pulmonary fibrosis Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 SDF-1 is an antifibrotic mediator in vivo Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 AZD3199: A potent and selective β2-adrenergic receptor agonist with rapid onset of action Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond Source: Eur Respir J, 56 (2) 2001610; 10.1183/13993003.01610-2020 Year: 2020 The in vitro biology of Compound X – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008 Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation Source: ERJ Open Res, 6 (3) 00121-2020; 10.1183/23120541.00121-2020 Year: 2020 In vitro pharmacological profile of CHF 5407, a potent, long-acting and selective muscarinic M3 receptor antagonist Source: Eur Respir J 2007; 30: Suppl. 51, 25s Year: 2007 A potential new therapy for pulmonary hypertension with the use of compound 21, an angiotensin type 2 receptor (AT2R) agonist Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Different alcohols activate airway sensory nerves by a vanilloid receptor 1 (TRPV1) dependent mechanism Source: Eur Respir J 2003; 22: Suppl. 45, 415s Year: 2003 Protective effect of leukotriene receptor antagonist montelukast in bleomycin induced pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Protease-activated receptor 2 (PAR2) stimulation potentiates citric acid induced cough by sensitising the vanilloid receptor-1 (TRPV1) Source: Annual Congress 2003 - Novel drugs under development for the treatment of respiratory diseases Year: 2003 Ethanol (EtOH) enhances the transient receptor potential vanilloid 1 (TRPV1) dependent cough in the guinea pig Source: Eur Respir J 2004; 24: Suppl. 48, 94s Year: 2004 Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 A new ultra-potent vanilloid receptor 1 (VR1) antagonist abates capsaicin and citric acid induced cough Source: Eur Respir J 2002; 20: Suppl. 38, 190s Year: 2002 Abrogation of bleomycin induced inflammation and lung fibrosis by angiotensin AT1 receptor antagonist. Relevance of PGE-2 modulation Source: Eur Respir J 2005; 26: Suppl. 49, 82s Year: 2005